Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to rise 26.60% to -6 cents per share on November 11
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 495.79K shares outstanding, the current market capitalization sits at 462.39M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LAB showed earnings on August 11, 2025. You can read more about the earnings report here.